(0.33%) 5 116.60 points
(0.32%) 38 361 points
(0.37%) 15 987 points
(-0.97%) $83.04
(5.36%) $2.03
(0.30%) $2 354.30
(0.42%) $27.65
(4.13%) $960.20
(-0.27%) $0.932
(-0.46%) $10.97
(-0.59%) $0.796
(1.66%) $93.40
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 6.78%
@ $32.67
発行日: 15 2月 2024 @ 00:30
リターン: -19.93%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -0.34 %
Live Chart Being Loaded With Signals
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 5 052.00 |
平均出来高 | 64 775.00 |
時価総額 | 372.41M |
EPS | $0 ( 2024-04-24 ) |
次の収益日 | ( $-0.360 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 67.08 |
ATR14 | $0.0890 (0.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-08 | Bedoya Jose H | Buy | 3 932 | Common Stock |
2024-02-08 | Bedoya Jose H | Buy | 1 803 | Common Stock |
2024-02-08 | Bedoya Jose H | Sell | 2 954 | Common Stock |
2024-02-08 | Bedoya Jose H | Buy | 3 853 | Stock Option (right to buy) |
2024-02-08 | Bedoya Jose H | Sell | 3 932 | Stock Option (right to buy) |
INSIDER POWER |
---|
62.04 |
Last 100 transactions |
Buy: 596 624 | Sell: 112 163 |
ボリューム 相関
Surmodics Inc 相関
10 最も負の相関 | |
---|---|
RAMMU | -0.896 |
OCUL | -0.889 |
MORF | -0.889 |
VRCA | -0.881 |
PLYA | -0.875 |
RIVE | -0.873 |
GEOS | -0.872 |
RAM | -0.868 |
SJ | -0.866 |
CNCE | -0.865 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Surmodics Inc 相関 - 通貨/商品
Surmodics Inc 財務諸表
Annual | 2023 |
収益: | $132.58M |
総利益: | $61.02M (46.03 %) |
EPS: | $-0.110 |
FY | 2023 |
収益: | $132.58M |
総利益: | $61.02M (46.03 %) |
EPS: | $-0.110 |
FY | 2022 |
収益: | $99.95M |
総利益: | $29.00M (29.01 %) |
EPS: | $-1.960 |
FY | 2021 |
収益: | $105.14M |
総利益: | $41.23M (39.21 %) |
EPS: | $0.310 |
Financial Reports:
No articles found.
Surmodics Inc
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。